# SILDENAFIL CITRATE
> **ANDA213014** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2021-05-11
## Drug
- **FDA Application Number:** ANDA213014
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** SILDENAFIL POWDER,
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2021-05-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213014)
---
*MORVS · CC0 1.0*